com Ltd. 97. 57 billion. 78% in the last one year. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. Market Capitalization. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. With about 151 holdings, it effectively. With about 156 holdings, it effectively. Netherlands. Top 10 Holdings. The fund’s NAV was $81. XBI Description. by Morningstar Manager Research. S. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. 79 as the 52 week high point — that compares with a last trade of $76. Price Chart. 73. 0. 1% and 1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. Implied XBI Analyst Target Price: $135. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment Research Learn everything about SPDR S&P Biotech ETF (XBI). 81% of the total fund's. There is no guarantee the funds will achieve their stated investment objectives. While this ETF allocates. 79 as the 52 week high point — that compares with a last trade of $126. Shares of Amgen , IBB's top holding with a weight of 8. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style,. Both VHT and XBI are ETFs. In seeking to track the performance of the S&P Biotechnology Select. Latest Holdings, Performance, AUM (from 13F, 13D) XBI - SPDR (R) S&P (R) Biotech ETF has disclosed 142 total holdings in their latest SEC filings. $7. The company’s fifty day. Performance and Risk. Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron (REGN). S. Looking at the chart above, XBI's low point in its 52 week range is $62. XBI focuses on health care investments and follows the S&P Biotech Index. XBI has traded between $62. 75. XBI: SPDR S&P Biotech ETF - Fund Holdings. 13 and $94. In contrast, most. 33% from the latest price. 33% so far, and is up roughly 4. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. 81 and $134. 97. The top ten holdings in IBB make up 51% of the fund, while the top ten in XBI only account for 12% of the fund. Discover historical prices for XBI stock on Yahoo Finance. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Skip to main content. Total healthcare and life sciences M&A was about $71. Real Estate ETFs. 80% of total assets under management. 7. 4% of the stocks in our database. The fund tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. 2 %. If Moderna's share price. 88%. More XBI Holdings Current Portfolio Date Nov 20, 2023; Equity Holdings 132; Bond Holdings 0; Other Holdings 3 % Assets in Top 10 Holdings 16. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. View complete XLP exchange traded fund holdings for better informed ETF trading. XBI, whose index recently expanded, also owns only a handful of established biotech companies. XBI's top 10 holdings account for about 11. Jun 23, 2022 10:49AM EDT. 79 in February 2021 and has fallen over (50%) to $76. Free ratings, analyses, holdings, benchmarks, quotes, and news. XBI is lower by 45% over the past two years, while the S&P 500 ETF (SPY Quick Quote SPY - Free Report) is higher by 8. View the XBI funds market news. The Global X Nasdaq 100 Covered Call ETF (QYLD) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Nasdaq 100 Index and “writes” or “sells” corresponding call options on the same index. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). 01 to $0. 1% and 1. SPDR S&P Biotech ETF ETF holdings by MarketWatch. com if you have any further questions. 69% allocation. Currency in USD. Performance and Risk The ETF has lost about -9. 51 on Tuesday. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. Both LABU and XBI are ETFs. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). 2. total market composite index. 65%. . At midday the XBI is rebounding indicating there is buying interest near $101. Free ratings, analyses, holdings, benchmarks, quotes, and news. m. 06 as the 52 week high point — that compares with a last trade of $102. Both VHT and XBI are ETFs. 77. 60 as the 52 week high point — that compares with a last trade of $77. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Performance and Risk So far this year, XBI has added roughly 1. Below is the comparison between BBC and XBI. 26%. Download as Image. 9%. Quote. Looking at the chart above, XBI's low point in its 52 week range is $97. $156. 94 per share, with $116. All 142 XBI Holdings. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. ETF Summary. 97. In addition, the recent spike in volatility has increased option prices even. Toggle navigationNovavax Inc. 51. Find exchange traded funds (ETFs) whose sector aligns with the same commodity grouping as the symbol you are viewing. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. 2013. Per cent of portfolio in top 5 holdings: 8. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . Performance and Risk. 35%. This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. View complete YINN exchange traded fund holdings for better informed ETF trading. XBI touched $73. XBI: SPDR® S&P Biotech ETF: 1. 19%. XBI: Head-To-Head ETF Comparison. $6. Lenders are funds or individuals that own the security that have indicated to. 47% vs -5. 66 +2. Analyst Forecast. 47%. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. 0. The XBI broke out in Q3 2016 and again in June 2017. Start Free Trial. Stocks. 10% of. Looking at the chart above, XBI's low point in its 52 week range is $62. Summary. Learn everything about SPDR S&P Biotech ETF (XBI). SPDR® S&P Biotech ETF (XBI) latest earnings report: revenue, EPS, surprise, history, news and analysis. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. For investors that want to rely on modern portfolio theory rather than assessing biotechnology companies, this is a solid option. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. SPDR® S&P Biotech ETF. Meanwhile, XBI equal weights its holdings. 84. 35%. There are 10 biotech ETFs that trade in the United States,. View the latest SPDR S&P Biotech ETF (XBI) stock price, news, historical charts, analyst ratings and financial information from WSJ. 12% in the last one year (as. . 04%. 58%). $36. Looking at the chart above, XBI's low point in its 52 week range is $115. View complete XBI exchange traded fund holdings for better informed ETF trading. LABD. 83%: Other: 0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. XBI Holdings5 Beaten-Down ETFs to Buy Now. 50(-0. In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. The famed investor's Berkshire Hathaway (. This table shows the interest rate that must be paid by a short seller of US:XBI to the lender of that security. According to data from U. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. No, even the large cap biotechs get pumped before a final FDA decision on a drug in their pipeline and usually have a sell off after on profit taking or a failed decision. February 15, 2023 — 10:47 am EST. Some of the top XBI holdings continue to defy the bear market. $0. large-cap stocks. 32% of the total portfolio assets. 7% of assets. Health Care Select Sector SPDR ETF ETF holdings by MarketWatch. 88 ; Annual Dividend & Yield 0. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. XBI vs BBH. 79 as the 52 week high point — that compares with a last trade of $116. 86% so far this year and is down about -32. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. 78% of XBI's total assets under management. 68%. Top 10 Holdings (14. NEW: Experience our best charts yet. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P. 18% and is down about -39. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. 37% in the last one. 78% so far this year and in the past one year (as of 11/20/2023), respectively. A list of holdings for XBI (SPDR S&P BIOTECH ETF) with details about each stock and its percentage weighting in the ETF. 17. IBB vs. During this past 52-week period, the fund has traded between. 45% vs 0. 0. 2% Category Average. Assets Under Management. 01 per share, with $174. Of course the mega caps are less volatile in general for any sector. 01%). 2. 54%. 85. Holdings. Dividend ETFs. 12% in the. 16bn USD. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. NAV as of Nov 16, 2023. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U. VHT vs XBI. 2. 2013. IMVT. 94 per share, with $174. Comparing XBI with other biotech ETFs, we note that XBI is one of the largest with around US$8 billion in assets under management and has one of the lowest expense ratios at 0. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. 79 as the 52 week high point — that compares with a last trade of $133. No company usually makes up more than two percent of. IBB vs. Asset type; Sector; Region; Asset type. XBI is an equal-weight passively-managed biotech ETF while ARKG is an actively-managed genomics ETF. Rated on Jun 30, 2023 Published on Jun 30. Further, the fund owns $6. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. Net Expense Ratio. 12% in the. 58%: Halozyme Therapeutics Inc:XLY News. BIIB is also in the top 15 XBI holdings. 01% vs 0. While this ETF allocates. XBI. 39M), JPMorgan Chase & Co. Assets Under Management. Looking at the chart above, XBI's low point in its 52 week range is $62. Holdings. 6% of the fund. 48%: Number of Holdings 78: Price/Book Ratio Price/Book Ratio. As I understand it, this attribute was added to the methodology to protect against having too. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI. Chart. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. FBT has a higher 5-year return than XBI (-0. Neena Mishra May 10, 2023. 16bn USD. 01% upside for this ETF looking through to the average analyst targets of the underlying holdings. 84%: Other: 0. 3. , respectively. 24 per unit, that means that analysts see 75. Like IBB, XBI uses diversification to. All 33 ARKK ETF Holdings. Investo S&P Biotech Sel Industry ETF IE. Holdings. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). The top holding in XBI receives just a 1. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. VHT has a. Holdings. There is no guarantee the fund will achieve its stated investment objective. ( AMGN) = 9. Below is the comparison between IBB and XBI. The fee is slightly higher for SBIO - . Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol. 0. ARKK ARKG. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. XBI’s Holdings. 01% vs 8. ETF Channel Staff - Friday, October 20, 6:48 AM. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, highlights the best rated ETF in the Emerging Markets Equities category. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. 08%. ETF Report Card. , including minimum market capitalization and. Up vote for PJP but it is pharmaceutical focused and technically not as broad as other biotech ETF's, though the top 10 holdings are comparable. Holdings. Both ARKG and XBI are ETFs. Minafi categorizes both of these funds as large funds. In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. Trades. 17% for the trailing three-year period, which makes XBI a high. In its most recent earnings release, President and Chief Executive Officer Christopher A. 66 +2. 23%) Advertisement SPDR S&P Biotech ETF (XBI) NYSEArca - NYSEArca Delayed Price. Better trading starts here. 9. com) ReturnsXBI's top 10 holdings account for about 10. Royal Gold Inc. 03 per $1,000 of principal). Learn everything about iShares Biotechnology ETF (IBB). With XBI trading at a recent price near $131. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). MRTX. 5% position, and no other holding accounts for more than 1. XBI has traded between $62. 10 as of November 2, 2022. February 15, 2023 — 10:47 am EST. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. Morningstar Medalist Rating. 81. XBI ETF’s holdings offer significant diversification. 01M), Whalerock Point Partners LLC ($343. Discover historical prices for XBI stock on Yahoo Finance. The ETF has lost about -12. Also I like this style of etf from power shares because the holdings are less weighted in the top two powerhouses (Amgen and Gilead for PJP) than "traditional" ETF's. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. Looking at the chart above, XBI's low point in its 52 week range is $61. In addition to holding 155 positions, its top 10 holdings make up just 14. 15 per share, with $174. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Snapshot for the SPDR S&P BIOTECH ETF ETF (XBI), including recent quote, performance, objective, analyst opinions, and commentary. 35%). 51 on Tuesday. Mettler-Toledo International Inc. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. Nov 20, 2023Top 10 Holdings. Visitors trend 2W 10W 9M. 67% Top 10 holdings are 16. XBI has a beta of 0. Holdings AS OF 04/30/2023. It can be found in the fund’s most recent prospectus. In addition to holding 155 positions, its top 10. Performance and Risk The ETF has lost about -29. . Thu, Nov 9, 1:16 PM ET, Market News Video. 01 to $0. 75M), Brown Advisory. 43. ETFs are subject to market fluctuation and the risks of their underlying investments. ETF strategy - SPDR® S&P BIOTECH ETF - Current price data, news, charts and performanceSee the company profile for SPDR S&P Biotech ETF (XBI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. Rather than analyzing the holdings of all ETFs and deciding which allocation is best it is easier to pick two that encompass large caps FBIOX or IBB and small/mid caps with equal weighting like the XBI. According to data from U. Company specialized in: Holding Companies. Top 10 Holdings (16. 2B Total Assets 0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Seeks to track a modified. As of 09/30/2023. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. The fund has a beta of 0. 58 💸. VICTORIA, BC / ACCESSWIRE / September 27, 2023 / Boron One Holdings Inc. Latest SPDR® S&P Biotech ETF (XBI:PCQ:USD) share price with interactive charts, historical prices, comparative analysis, forecasts,. Export data to Excel for your own analysis. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 0. XBI Holdings 5 Beaten-Down ETFs to Buy Now. The weighted harmonic average of closing market price divided by. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). 67. 79 as the 52 week high point — that compares with a last trade of $159. VHT has a higher 5-year return than XBI (7. ARKK Holdings / CRSP / ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily. 72%: Data delayed at least 15 minutes, as of Nov 16 2023 21:00 GMT. Holdings; Performance; Risk; Performance Overview-12. S. Holdings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 5. That's the main advantage to investing. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. 01%). 80 per share, with $92. The top 10 holdings account for about 10. This type of methodology gives the smaller companies a greater importance in the fund thereby amplifying the gains and losses from small. 2015. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. Below is the comparison between FBT and XBI. XBI, BEAM, FATE, NTLA: ETF Outflow Alert. XBI has traded between $62. As previously mentioned, the biotech industry is relatively unpredictable, and a company’s success is more binary in this industry than in other sectors of the economy. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. For an ETF, this widget displays the top 10 constituents that make up the fund. 0 reviews. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. XLV comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. Compare ETFs XBI and IBB on performance, AUM, flows, holdings, costs and ESG ratings. comSPDR S&P Biotech ETF is a equity fund issued by SSgA. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. Discover historical prices for XBI stock on Yahoo Finance. XBI has traded between $64. It can be found in the fund’s most recent prospectus. The following charts reflect the geographic spread of WCLD's underlying holdings. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. 71%: Number of Holdings 64: Price/Book Ratio Price/Book Ratio.